8-K: XWELL Q3 2025: Revenue $7.3M, Cost Cuts, Global Expansion

XWELL, Inc. announced its third quarter 2025 financial results, reporting $7.3 million in revenue and significant cost reductions while expanding its wellness solutions globally.

Summary

• Revenue for the third quarter ended September 30, 2025, totaled $7.3 million.
• Cost of sales decreased approximately 8% from the 2024 third quarter to $5.9 million.
• General and administrative expenses, excluding one-time credits, decreased approximately 32% from the 2024 third quarter.
• Operating loss significantly improved to $0.8 million for Q3 2025, compared to $4.8 million in the comparable prior year period.
• Net loss attributable to XWELL improved to $0.7 million for Q3 2025, compared to $4.8 million in the comparable prior year period.
• Subsequent to the end of the third quarter, XWELL streamlined its cost structure, reducing approximately $2.4 million in annualized staffing costs and integrating its HyperPointe business.
• The Priority Pass partnership has been expanded to key international airports across the Middle East and Europe.
• New brick-and-mortar locations opened at Waterford Lakes Town Center and Bloomingdale Square in Florida, with a Penn Station, New York City location set to open in mid-November.
• XWELL secured a three-year extension of its Traveler-based Genomic Surveillance Program (TGS) with the CDC and Ginkgo Bioworks Holdings in March 2025.
• The biosecurity platform is positioned for new international growth opportunities at major global events such as the 2026 World Cup, the Haj, and the 2026 and 2028 Olympics.

Sentiment

Score: 7

Explanation: The company showed significant improvement in reducing losses and operating expenses, coupled with strategic expansions and cost-cutting measures. While still operating at a loss, the trajectory is positive, indicating effective management actions and growth initiatives.

Positives

• Operating loss significantly improved from $4.8 million in Q3 2024 to $0.8 million in Q3 2025.
• Net loss attributable to XWELL improved substantially from $4.8 million in Q3 2024 to $0.7 million in Q3 2025.
• Cost of sales decreased approximately 8% from Q3 2024 to $5.9 million.
• General and administrative expenses, excluding one-time credits, decreased approximately 32% from Q3 2024.
• Implemented cost streamlining measures subsequent to Q3, reducing approximately $2.4 million in annualized staffing costs.
• Expanded Priority Pass partnership globally to the Middle East and Europe, broadening access to wellness offerings.
• Opened new off-airport wellness centers in Florida and a planned opening in Penn Station, NYC, diversifying access points.
• Secured a three-year extension of the Traveler-based Genomic Surveillance Program (TGS) with the CDC and Ginkgo Bioworks Holdings in March 2025.
• Strong liquidity position with $4.0 million in cash and cash equivalents and no long-term debt as of September 30, 2025.

Negatives

• The company still reported an operating loss of $0.8 million and a net loss of $0.7 million for the quarter, indicating it is not yet profitable.

Risks

• Forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from those indicated.
• Important factors that could cause actual results or events to differ materially are discussed from time to time in the Company's filings with the Securities and Exchange Commission (SEC), including its Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and proxy statements.

Future Outlook

XWELL anticipates continued growth by diversifying access points, elevating brand relevance, and engaging with consumers in various settings. The company plans to expand efficiently both inside and outside of airports, leveraging its digital platform and AI capabilities. Its biosecurity platform is positioned for new international growth opportunities at major global events like the 2026 World Cup, Haj, and the 2026 and 2028 Olympics. XWELL also continues to pursue opportunities to potentially acquire complementary businesses.

Management Comments

• "We believe we are making meaningful progress against our priorities from diversifying access points, elevating brand relevance, and engaging with consumers wherever wellness matters the most." Ezra Ernst, CEO
• "Our expanded partnership with Priority Pass builds on the tremendous response we’ve seen from travelers across our U.S. airport spas, while the openings of off-airport wellness centers in Penn Station and several Florida markets demonstrate how XWELL is successfully extending its services to customers where they live, work, and travel." Ezra Ernst, CEO
• "Supported by our long-standing CDC partnership, ongoing operational discipline and targeted growth strategy, I am confident in the opportunities that lie ahead for XWELL." Ezra Ernst, CEO
• "While decisions like these are never easy, with our operational foundation and infrastructure now in order, we believe XWELL remains well-positioned to expand efficiently both inside and outside of airports." Ezra Ernst, CEO

Industry Context

XWELL's expansion beyond airport terminals into broader consumer wellness markets, including retail centers and transportation hubs, aligns with a growing trend of integrating wellness services into daily life and travel. The global expansion of its Priority Pass partnership reflects the increasing demand for premium airport experiences. The continued focus on biosecurity, particularly with the CDC partnership and targeting major global events, positions XWELL at the forefront of public health initiatives in high-traffic environments, a sector gaining significant importance post-pandemic.

Stakeholder Impact

• Shareholders: Potential positive impact from improved financial performance, strategic growth, and cost efficiencies, aiming for reduced losses and future profitability.
• Employees: Impacted by staffing cost reductions (approximately $2.4 million annualized staffing costs removed), suggesting some workforce adjustments.
• Customers/Travelers: Benefit from expanded wellness offerings through Priority Pass in new international airports and new off-airport locations, providing broader access to services.
• Partners (CDC, Ginkgo Bioworks, Priority Pass, Orlando Magic): Strengthened relationships and extended collaborations, indicating continued mutual benefits and program stability.

Next Steps

• Opening of the Penn Station, NYC location in mid-November.
• Continued plans to grow beyond airports with new brick-and-mortar locations.
• Pursuing opportunities to potentially acquire complementary businesses.
• Leveraging biosecurity platform for international growth opportunities at events like the 2026 World Cup, the Haj, 2026 Winter Olympics, and 2028 Summer Olympics.

Key Dates

Recommendation

While XWELL demonstrated significant improvements in reducing its operating and net losses, along with strategic expansions and cost-cutting initiatives, it is still operating at a loss. The positive trajectory and growth initiatives are encouraging, but sustained profitability has not yet been achieved. Investors should hold to observe if these strategic moves translate into consistent positive earnings and cash flow in subsequent quarters before considering a stronger position.

Keywords

XWELL, XWEL, Q3 2025 Earnings, Financial Results, Wellness Solutions, XpresSpa, XpresCheck, Naples Wax Center, Biosecurity, CDC Partnership, Priority Pass, Airport Wellness, Travel Wellness, Cost Reduction, Staffing Costs, HyperPointe, Orlando Magic, Genomic Surveillance